Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2016-06-21
|
Halaven® (eribulin) |
advanced breast cancer |
preclinical |
Eisai (Japan) |
Cancer - Oncology |
2016-06-21
|
TD-6450 and faldaprevir |
hepatitis C |
2a |
Trek Therapeutics (USA - MA) |
Infectious diseases |
2016-06-21
|
Yeliva™ (ABC294640) |
advanced solid tumors |
1 |
Redhill Biopharma (Israel) |
Cancer - Oncology |
2016-06-20
|
Bekinda™(extended-release formulation of ondansetron) |
irritable bowel syndrome |
2 |
Redhill Biopharma (Israel) |
Digestive diseases - Gastrointestinal diseases - Inflammatory diseases |
2016-06-20
|
GBT440 |
idiopathic pulmonary fibrosis and hypoxemia |
2a |
Global Blood Therapeutics (USA - CA) |
Lung diseases - Respiratory diseases - Rare diseases |
2016-06-20
|
lefamulin (BC 3781) |
|
preclinical |
Nabriva Therapeutics (Austria) |
Infectious diseases |
2016-06-20
|
bictegravir (GS-9883) |
HIV-1 infection |
1 |
Gilead Sciences (USA - CA) |
Infectious diseases |
2016-06-17
|
MOR208 |
Non-Hodgkin's Lymphoma (NHL) |
2 |
Morphosys (Germany) |
Cancer - Oncology |
2016-06-17
|
ABX203 |
hepatitis B |
2b-3 |
Abivax (France) |
Infectious diseases |
2016-06-17
|
ASN200 program including ASN-4 |
multi-drug resistant Escherichia coli infection |
preclinical |
Arsanis (USA - MA) |
Infectious diseases |
2016-06-17
|
AM-111 |
idiopathic sudden sensorineural hearing loss |
3 |
Auris Medical (Switzerland) |
Otorhinolaryngology |
2016-06-16
|
pidilizumab |
diffuse intrinsic pontine glioma (DIPG) |
1-2 |
Hadassah Medical Organization (Israel) Medivation (USA - CA) |
Cancer - Oncology - Rare diseases |
2016-06-16
|
Keytruda® (pembrolizumab - MK-3475) |
non-small-cell lung carcinoma |
3 |
Merck&Co (USA - NJ) |
Cancer - Oncology |
2016-06-16
|
resminostat (oral pan-histone deacetylase (HDAC) inhibitor) |
|
preclinical |
4SC (Germany) |
Cancer - Oncology |
2016-06-16
|
ONS-3010 (biosimilar version of Humira® (adalimumab)) |
moderate to severe plaque psoriasis |
3 |
Oncobiologics (USA - NJ) |
Autoimmune diseases - Dermatological diseases |
2016-06-15
|
Apocept™ (APG101 - asunercept) |
myelodysplastic syndromes |
1 |
Apogenix (Germany) |
Cancer - Oncology |
2016-06-14
|
plitidepsin |
angioimmunoblastic T-cell lymphoma |
2 |
PharmaMar (Spain) |
Cancer - Oncology - Rare diseases |
2016-06-13
|
GALE-401 (anagrelide controlled release ) |
|
2 |
Galena Biopharma (USA - OR) |
Cancer - Oncology - Hematological diseases |
2016-06-13
|
SPK-8011 |
hemophilia A |
preclinical |
Spark Therapeutics (USA - PA) |
Rare diseases - Genetic diseases - Hematological diseases |
2016-06-12
|
inotuzumab ozogamicin |
relapsed or refractory CD22-positive acute lymphoblastic leukemia (ALL) |
3 |
Pfizer (USA - NY) |
Cancer - Oncology |